Bris­tol My­ers’ lead deal ne­go­tia­tor to de­part af­ter ink­ing se­ries of multi­bil­lion-dol­lar ac­qui­si­tions

Eliz­a­beth Mi­ly, the lead ac­qui­si­tion and deal ne­go­tia­tor at Bris­tol My­ers Squibb, is leav­ing the Big Phar­ma, a spokesper­son con­firmed to End­points News on Fri­day morn­ing.

Since join­ing Bris­tol My­ers in the spring of 2020 as EVP of strat­e­gy and busi­ness de­vel­op­ment, Mi­ly had helped or­ches­trate a trio of multi­bil­lion-dol­lar ac­qui­si­tions, two of which have beefed up the phar­ma gi­ant’s on­col­o­gy port­fo­lio and an­oth­er that has spurred its push in car­dio­vas­cu­lar dis­eases.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER